O	0	2	Ca	Ca	NN	B-NP
O	2	3	+	+	SYM	O
O	3	4	+	+	SYM	O
O	5	17	distribution	distribution	NN	B-NP
O	18	23	after	after	IN	B-PP
O	24	26	Na	Na	NN	B-NP
O	26	27	+	+	SYM	B-NP
O	28	32	pump	pump	NN	I-NP
O	33	43	inhibition	inhibition	NN	I-NP
O	44	46	in	in	IN	B-PP
O	47	55	cultured	culture	VBN	B-NP
O	56	64	neonatal	neonatal	JJ	I-NP
O	65	68	rat	rat	NN	I-NP
B-Cell	69	79	myocardial	myocardial	JJ	I-NP
I-Cell	80	85	cells	cell	NNS	I-NP
O	85	86	.	.	.	O

O	87	90	The	The	DT	B-NP
O	91	100	influence	influence	NN	I-NP
O	101	103	of	of	IN	B-PP
O	104	114	inhibition	inhibition	NN	B-NP
O	115	117	of	of	IN	B-PP
O	118	121	the	the	DT	B-NP
O	122	124	Na	Na	NN	I-NP
O	124	125	+	+	SYM	B-NP
O	126	130	pump	pump	NN	I-NP
O	130	131	,	,	,	O
O	132	136	with	with	IN	B-PP
O	137	146	secondary	secondary	JJ	B-NP
O	147	158	stimulation	stimulation	NN	I-NP
O	159	161	of	of	IN	B-PP
O	162	164	Na	Na	NN	B-NP
O	164	165	+	+	SYM	B-NP
O	165	166	-	-	HYPH	B-NP
O	166	168	Ca	Ca	NN	I-NP
O	168	169	+	+	SYM	O
O	169	170	+	+	SYM	O
O	171	179	exchange	exchange	NN	B-NP
O	179	180	,	,	,	O
O	181	183	on	on	IN	B-PP
B-Cell	184	192	cellular	cellular	JJ	B-NP
O	193	195	Ca	Ca	NN	I-NP
O	195	196	+	+	SYM	O
O	196	197	+	+	SYM	O
O	198	210	distribution	distribution	NN	B-NP
O	211	213	is	be	VBZ	B-VP
O	214	222	examined	examine	VBN	I-VP
O	223	228	using	use	VBG	I-VP
O	229	232	the	the	DT	B-NP
O	233	235	on	on	IN	B-PP
O	235	236	-	-	HYPH	B-NP
O	236	240	line	line	NN	I-NP
O	241	254	scintillation	scintillation	NN	I-NP
O	255	259	disk	disk	NN	I-NP
O	260	269	technique	technique	NN	I-NP
O	270	273	and	and	CC	O
O	274	282	cultured	culture	VBN	B-NP
O	283	291	neonatal	neonatal	JJ	I-NP
O	292	295	rat	rat	NN	I-NP
B-Cell	296	306	myocardial	myocardial	JJ	I-NP
I-Cell	307	312	cells	cell	NNS	I-NP
O	312	313	.	.	.	O

O	314	319	Under	Under	IN	B-PP
O	320	327	control	control	NN	B-NP
O	328	338	conditions	condition	NNS	I-NP
O	338	339	,	,	,	O
O	340	342	La	La	NN	B-NP
O	342	343	+	+	SYM	B-VP
O	343	344	+	+	SYM	B-NP
O	344	345	+	+	SYM	B-NP
O	346	355	displaced	displace	VBD	B-VP
O	356	358	78	78	CD	B-NP
O	358	359	.	.	SYM	I-NP
O	359	360	1	1	CD	I-NP
O	361	362	+	+	SYM	O
O	362	363	/	/	SYM	O
O	363	364	-	-	SYM	B-NP
O	365	366	1	1	CD	I-NP
O	366	367	.	.	SYM	I-NP
O	367	369	13	13	CD	I-NP
O	369	370	%	%	NN	I-NP
O	371	372	(	(	(	O
O	372	375	SEM	SEM	NN	B-NP
O	375	376	)	)	)	O
O	377	379	of	of	IN	B-PP
O	380	383	the	the	DT	B-NP
O	384	389	total	total	JJ	I-NP
B-Cell	390	394	cell	cell	NN	I-NP
O	395	405	associated	associate	VBN	B-VP
O	406	410	45Ca	45Ca	NN	B-NP
O	410	411	.	.	.	O

O	412	423	Application	Application	NN	B-NP
O	424	426	of	of	IN	B-PP
O	427	428	1	1	CD	B-NP
O	429	431	mm	mm	NN	I-NP
O	432	439	ouabain	ouabain	NN	I-NP
O	440	442	or	or	CC	I-NP
O	443	452	reduction	reduction	NN	I-NP
O	453	455	of	of	IN	B-PP
O	456	457	[	[	(	O
O	457	458	K	K	NN	O
O	458	459	+	+	SYM	O
O	459	460	]	]	)	O
O	460	461	o	o	NN	B-NP
O	462	464	to	to	TO	B-PP
O	465	466	0	0	CD	B-NP
O	466	467	.	.	.	O
O	467	468	5	5	CD	B-NP
O	469	471	mM	mM	NN	I-NP
O	472	480	resulted	result	VBD	B-VP
O	481	483	in	in	IN	B-PP
O	484	485	a	a	DT	B-NP
O	486	489	net	net	JJ	I-NP
O	490	498	increase	increase	NN	I-NP
O	499	501	of	of	IN	B-PP
O	502	504	10	10	CD	B-NP
O	504	505	.	.	.	O
O	505	506	6	6	CD	B-NP
O	507	508	+	+	SYM	B-NP
O	508	509	/	/	SYM	I-NP
O	509	510	-	-	SYM	I-NP
O	511	512	1	1	CD	I-NP
O	512	513	.	.	SYM	I-NP
O	513	514	3	3	CD	I-NP
O	514	515	%	%	NN	I-NP
O	516	519	and	and	CC	O
O	520	522	13	13	CD	B-NP
O	522	523	.	.	.	O
O	523	524	8	8	CD	B-NP
O	525	526	+	+	SYM	O
O	526	527	/	/	SYM	O
O	527	528	-	-	SYM	O
O	529	530	2	2	CD	B-NP
O	530	531	%	%	NN	I-NP
O	531	532	,	,	,	O
O	533	545	respectively	respectively	RB	B-ADVP
O	545	546	,	,	,	O
O	547	549	in	in	IN	B-PP
O	550	555	total	total	JJ	B-NP
B-Cell	556	560	cell	cell	NN	I-NP
O	560	561	-	-	HYPH	B-NP
O	561	571	associated	associate	VBN	I-NP
O	572	574	Ca	Ca	NN	I-NP
O	574	575	+	+	SYM	B-NP
O	575	576	+	+	SYM	B-NP
O	576	577	.	.	.	O

O	578	580	Of	Of	IN	B-PP
O	581	585	this	this	DT	B-NP
O	586	591	added	add	VBN	I-NP
O	592	596	45Ca	45Ca	NN	I-NP
O	596	597	,	,	,	O
O	598	600	75	75	CD	B-NP
O	600	601	.	.	.	O
O	601	602	9	9	CD	B-NP
O	603	604	+	+	SYM	O
O	604	605	/	/	SYM	O
O	605	606	-	-	SYM	B-NP
O	607	608	2	2	CD	B-NP
O	608	609	.	.	SYM	I-NP
O	609	610	7	7	CD	I-NP
O	610	611	%	%	NN	I-NP
O	612	615	and	and	CC	I-NP
O	616	618	78	78	CD	I-NP
O	618	619	.	.	.	I-NP
O	619	620	4	4	CD	I-NP
O	621	622	+	+	SYM	O
O	622	623	/	/	SYM	O
O	623	624	-	-	SYM	B-NP
O	625	626	2	2	CD	B-NP
O	626	627	.	.	SYM	I-NP
O	627	628	1	1	CD	I-NP
O	628	629	%	%	NN	I-NP
O	629	630	,	,	,	O
O	631	643	respectively	respectively	RB	B-ADVP
O	644	652	remained	remain	VBD	B-VP
O	653	655	La	La	NN	B-NP
O	655	656	+	+	SYM	O
O	656	657	+	+	SYM	B-NP
O	657	658	+	+	SYM	B-VP
O	658	659	-	-	HYPH	B-NP
O	659	671	displaceable	displaceable	JJ	B-ADJP
O	671	672	.	.	.	O

O	673	676	The	The	DT	B-NP
O	677	681	45Ca	45Ca	NN	I-NP
O	681	682	-	-	HYPH	B-VP
O	682	689	binding	bind	VBG	B-NP
O	690	705	characteristics	characteristic	NNS	I-NP
O	706	708	of	of	IN	B-PP
O	709	717	isolated	isolate	VBN	B-NP
B-Cellular_component	718	728	sarcolemma	sarcolemma	NN	I-NP
O	728	729	,	,	,	O
O	730	738	prepared	prepare	VBN	B-VP
O	739	743	from	from	IN	B-PP
O	744	747	the	the	DT	B-NP
O	748	756	cultured	culture	VBN	I-NP
O	757	765	neonatal	neonatal	JJ	I-NP
O	766	769	rat	rat	NN	I-NP
B-Cell	770	780	myocardial	myocardial	JJ	I-NP
I-Cell	781	786	cells	cell	NNS	I-NP
O	787	792	using	use	VBG	B-VP
O	793	796	the	the	DT	B-NP
O	797	800	gas	gas	NN	I-NP
O	801	811	dissection	dissection	NN	I-NP
O	812	821	technique	technique	NN	I-NP
O	821	822	,	,	,	O
O	823	827	were	be	VBD	B-VP
O	828	836	examined	examine	VBN	I-VP
O	836	837	.	.	.	O

O	838	842	When	When	WRB	B-ADVP
O	843	850	treated	treat	VBN	B-VP
O	851	855	with	with	IN	B-PP
O	856	862	either	either	CC	O
O	863	870	ouabain	ouabain	NN	B-NP
O	871	873	or	or	CC	O
O	874	877	low	low	JJ	B-ADJP
O	878	879	[	[	(	O
O	879	880	K	K	NN	O
O	880	881	+	+	SYM	O
O	881	882	]	]	)	O
O	882	883	o	o	NN	B-NP
O	884	893	solutions	solution	NNS	I-NP
O	893	894	,	,	,	O
B-Cellular_component	895	906	sarcolemmal	sarcolemmal	JJ	B-NP
O	907	911	45Ca	45Ca	NN	I-NP
O	912	919	binding	binding	NN	I-NP
O	920	923	did	do	VBD	B-VP
O	924	927	not	not	RB	I-VP
O	928	934	change	change	VB	I-VP
O	934	935	.	.	.	O

O	936	940	This	This	DT	B-NP
O	941	947	result	result	NN	I-NP
O	948	957	indicates	indicate	VBZ	B-VP
O	958	962	that	that	IN	B-SBAR
O	963	973	functional	functional	JJ	B-NP
O	973	974	,	,	,	I-NP
O	975	981	intact	intact	JJ	I-NP
B-Tissue	982	988	tissue	tissue	NN	I-NP
O	989	991	is	be	VBZ	B-VP
O	992	1001	necessary	necessary	JJ	B-ADJP
O	1002	1004	to	to	TO	B-VP
O	1005	1012	observe	observe	VB	I-VP
O	1013	1016	the	the	DT	B-NP
O	1017	1019	Ca	Ca	NN	I-NP
O	1019	1020	+	+	SYM	B-VP
O	1020	1021	+	+	SYM	O
O	1022	1030	increase	increase	NN	B-NP
O	1030	1031	.	.	.	O

O	1032	1041	Treatment	Treatment	NN	B-NP
O	1042	1044	of	of	IN	B-PP
O	1045	1048	the	the	DT	B-NP
B-Cell	1049	1054	cells	cell	NNS	I-NP
O	1055	1059	with	with	IN	B-PP
O	1060	1069	verapamil	verapamil	NN	B-NP
O	1070	1076	before	before	IN	B-PP
O	1077	1080	and	and	CC	I-PP
O	1081	1087	during	during	IN	I-PP
O	1088	1095	ouabain	ouabain	NN	B-NP
O	1096	1104	exposure	exposure	NN	I-NP
O	1105	1111	failed	fail	VBD	B-VP
O	1112	1114	to	to	TO	I-VP
O	1115	1122	inhibit	inhibit	VB	I-VP
O	1123	1126	the	the	DT	B-NP
O	1127	1134	ouabain	ouabain	NN	I-NP
O	1134	1135	-	-	HYPH	B-VP
O	1135	1142	induced	induce	VBN	B-NP
O	1143	1151	increase	increase	NN	I-NP
O	1152	1154	in	in	IN	B-PP
B-Cell	1155	1159	cell	cell	NN	B-NP
O	1159	1160	-	-	HYPH	B-NP
O	1160	1170	associated	associate	VBN	I-NP
O	1171	1175	45Ca	45Ca	NN	I-NP
O	1175	1176	.	.	.	O

O	1177	1180	The	The	DT	B-NP
O	1181	1189	evidence	evidence	NN	I-NP
O	1190	1199	indicates	indicate	VBZ	B-VP
O	1200	1204	that	that	IN	B-SBAR
O	1205	1215	inhibition	inhibition	NN	B-NP
O	1216	1218	of	of	IN	B-PP
O	1219	1222	the	the	DT	B-NP
O	1223	1225	Na	Na	NN	I-NP
O	1225	1226	+	+	SYM	O
O	1226	1227	-	-	HYPH	O
O	1227	1231	pump	pump	NN	B-NP
O	1231	1232	,	,	,	O
O	1233	1236	and	and	CC	O
O	1237	1246	secondary	secondary	JJ	B-NP
O	1247	1258	stimulation	stimulation	NN	I-NP
O	1259	1261	of	of	IN	B-PP
O	1262	1264	Na	Na	NN	B-NP
O	1264	1265	+	+	SYM	B-NP
O	1265	1266	-	-	HYPH	B-NP
O	1266	1268	Ca	Ca	NN	I-NP
O	1268	1269	+	+	SYM	O
O	1269	1270	+	+	SYM	O
O	1271	1279	exchange	exchange	NN	B-NP
O	1279	1280	,	,	,	O
O	1281	1287	result	result	VBP	B-VP
O	1288	1290	in	in	IN	B-PP
O	1291	1292	a	a	DT	B-NP
O	1293	1296	net	net	JJ	I-NP
O	1297	1305	increase	increase	NN	I-NP
O	1306	1308	of	of	IN	B-PP
O	1309	1311	11	11	CD	B-NP
O	1311	1312	-	-	HYPH	I-NP
O	1312	1314	15	15	CD	I-NP
O	1314	1315	%	%	NN	I-NP
O	1316	1318	in	in	IN	B-PP
O	1319	1323	cell	cell	NN	B-NP
O	1323	1324	-	-	HYPH	B-NP
O	1324	1334	associated	associate	VBN	I-NP
O	1335	1337	Ca	Ca	NN	I-NP
O	1337	1338	+	+	SYM	B-NP
O	1338	1339	+	+	SYM	B-NP
O	1339	1340	,	,	,	O
O	1341	1343	78	78	CD	B-NP
O	1343	1344	%	%	NN	I-NP
O	1345	1347	of	of	IN	B-PP
O	1348	1353	which	which	WDT	B-NP
O	1354	1361	remains	remain	VBZ	B-VP
O	1362	1364	La	La	NN	B-NP
O	1364	1365	+	+	SYM	O
O	1365	1366	+	+	SYM	B-NP
O	1366	1367	+	+	SYM	O
O	1367	1368	-	-	HYPH	O
O	1368	1380	displaceable	displaceable	JJ	B-ADJP
O	1381	1384	and	and	CC	O
O	1385	1387	is	be	VBZ	B-VP
O	1387	1388	,	,	,	O
O	1389	1398	therefore	therefore	RB	B-ADVP
O	1398	1399	,	,	,	O
O	1400	1409	localized	localize	VBD	B-VP
O	1410	1412	to	to	TO	B-PP
O	1413	1416	the	the	DT	B-NP
B-Cellular_component	1417	1427	sarcolemma	sarcolemma	NN	I-NP
O	1427	1428	-	-	HYPH	B-NP
B-Cellular_component	1428	1438	glycocalyx	glycocalyx	NN	I-NP
O	1439	1446	complex	complex	NN	I-NP
O	1446	1447	.	.	.	O

